How to use Bufomix (Budesonide/Formoterol) Easyhaler Read more
Bufomix Easyhaler (Budesonide/Formoterol) Easyhaler Read more

Welcome to Wehale.life - website about asthma and COPD!
This section is intended for healthcare professionals in Ireland treating people with respiratory diseases. We offer you:

Insights on the scientific research and development behind Bufomix (budesonide/formoterol) Easyhaler^® therapy, the latest scientific publications and interviews of colleagues.
Patient support materials for you to use and guide your patients with Easyhaler^® DPI device.
Patient benefits introduces the main benefits that Easyhaler® offers to patients and physicians.
Product info contains essential information about Bufomix (budesonide/formoterol) Easyhaler^® the ICS/LABA combination therapy
On the Events you can find information on respiratory congresses, our educational events and key lectures of leading experts in pulmonology.

Product Info

Product info

Video: Show your patients how to access the supporting materials provided in the package, on the device and online.

Product info

Video: Easyhaler<sup>®</sup>: When you click more than once

Video: Easyhaler^®: When you click more than once

Product info

Video: Bufomix Easyhaler<sup>®</sup> (Budesonide/ Formoterol) for children 6 years and older

Video: Bufomix Easyhaler^® (Budesonide/ Formoterol) for children 6 years and older

Product info

Video: Easyhaler<sup>®</sup> inhalation technique

Video: Easyhaler^® inhalation technique

Product info

Video: What is wehale.life?

Product info

Video: Easyhaler^® in action

Product info

Bufomix Easyhaler<sup>®</sup> (Budesonide/ Formoterol)

Bufomix Easyhaler^® (Budesonide/ Formoterol)

Patient Support

Patient support

Bufomix Easyhaler<sup>®</sup> (Budesonide/Formoterol) Support Items

Bufomix Easyhaler^® (Budesonide/Formoterol) Support Items

Patient support

Bufomix Easyhaler<sup>®</sup> (Budesonide/Formoterol) Resources

Bufomix Easyhaler^® (Budesonide/Formoterol) Resources

Patient support

How to use Bufomix Easyhaler<sup>®</sup> (Budesonide/Formoterol)

How to use Bufomix Easyhaler^® (Budesonide/Formoterol)

Insights: Register to access this content

Insights

Managing COPD correctly leads to less exacerbations and better quality of life

Insights

Inadequate prescription, poor adherence, and errors in inhaler technique contribute to poor asthma control

Insights

Clinical effectiveness of Budesonide/Formoterol Fumarate Easyhaler<sup>® </sup> for patients with poorly controlled obstructive airway disease: a real-world study of patient-reported outcomes

Clinical effectiveness of Budesonide/Formoterol Fumarate Easyhaler^® for patients with poorly controlled obstructive airway disease: a real-world study of patient-reported outcomes

Insights

Switching to Bufomix (budesonide/formoterol) Easyhaler<sup>® </sup> improves disease control and health-related quality of life

Switching to Bufomix (budesonide/formoterol) Easyhaler^® improves disease control and health-related quality of life

Insights

Patients with asthma or COPD are able to efficiently use Easyhaler<sup>®</sup> regardless of age or disease severity

Patients with asthma or COPD are able to efficiently use Easyhaler^® regardless of age or disease severity

Insights

Dry powder inhalers – how to minimise handling errors and ensure patient satisfaction

Insights

Global Initiative for Asthma — What is new in GINA 2022?

Insights

Ability of patients with asthma to achieve correct inspiratory flow rates for different inhalers

Insights

Assessing patient inspiratory flow rate for clinical efficacy with<br> Bufomix (Budesonide/Formoterol) Easyhaler<sup>®</sup>

Assessing patient inspiratory flow rate for clinical efficacy with
Bufomix (Budesonide/Formoterol) Easyhaler^®

Insights

Evaluation of the efficiency of single-inhaler combination therapy with budesonide/formoterol fumarate in patients with bronchial asthma in daily clinical practice

Insights

Global strategy for prevention, diagnosis and management of COPD: Updates in the 2021 GOLD Report

Insights

Global Initiative for Asthma: Updates in the 2021 GINA Report

Insights

Switching to the Easyhaler Device to control Asthma and COPD: A literature review

Insights

Science says singing is good for COPD patients – 3 positive ways to relieve COPD symptoms

Insights

Let’s keep the planet breathing:<br> Bufomix (budesonide/formoterol) Easyhaler<sup>®</sup> is now fully carbon neutral

Let’s keep the planet breathing:
Bufomix (budesonide/formoterol) Easyhaler^® is now fully carbon neutral

Insights

The importance of patient satisfaction, preference, and adherence to inhaler for long-term asthma control

Insights

MART – Maintenance and Reliever Therapy – Asthma Management – Ideal Inhaler – Easyhaler

Insights

More asthma patients achieve the optimal inspiratory flow for high-resistance inhalers than for low-resistance inhalers

Insights

Complete life cycle of an Easyhaler assessed

Insights

Easy, convenient, and environmentally friendly asthma and COPD care with Easyhaler®

Insights

Comprehensive asthma care with Bufomix (budesonide/formoterol) Easyhaler<sup>®</sup> maintenance and reliever therapy (MART)

Comprehensive asthma care with Bufomix (budesonide/formoterol) Easyhaler^® maintenance and reliever therapy (MART)

Insights

Inhaler technical features and patient education in supporting successful treatment of asthma and COPD

Events

Orion at ERS International Congress 2021

ORIONPHARMA.IE

DATE OF PREPARATION: MAY 2023/EASYH-688(10)

FULL PRESCRIBING INFORMATION AVAILABLE HERE

For more information about Orion and Sustainability click here

Orion Pharma (Ireland) Ltd., C/o Allphar Services, 4045 Kingswood Rd,
Citywest Business Pk, Dublin 24. Tel +353 1 4687500
Date of Preparation: May 2023 / EASYH-638(8)

Welcome to Wehale.life - website about asthma and COPD! This section is intended for healthcare professionals in Ireland treating people with respiratory diseases. We offer you:

Product Info

Patient Support

Insights: Register to access this content

Events

Welcome to Wehale.life - website about asthma and COPD!
This section is intended for healthcare professionals in Ireland treating people with respiratory diseases. We offer you: